_id

690db3d5ccc777a4e85d0d0d

Ticker

AVTX

Name

Avalo Therapeutics Inc

Exchange

NASDAQ

Address

540 Gaither Road, Rockville, MD, United States, 20850

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.avalotx.com

Description

Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. Its lead asset includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.

Last Close

19.51

Volume

117997

Current Price

18.6

Change

-4.664274730907227

Last Updated

2025-11-28T12:36:40.079Z

Image

data:image/webp;base64,UklGRq4HAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSB4EAAABoEXbtmk7mmvt8xCnbNu2bdu2bdu2bduuim3bdt5ee82P93LuPSelz4iYAPzfLbLwiGYZmpYsSOkkCADUNG9eHxSABCmTBgAt1z/g7PcHzpo7unO7W4/cuxkgQcqiCqx5X5fJdC44tr94tYCgpZCAZsf9NJdkbEjJ3VOyBiNTu30gQUqg2LWTkxYT83pMZHxjdQQpwT2Rlki6RUtOMkVz0lPi+KNFtCDBfbTo9BSNjVMiSTcn3Zger4MUIqjvwAZP5mTs/sVLt5653TYHX/l2u6lkSqRHfr8EtBDBJr2Z6Bxy0a5tsOC6jW4eTzenR3ZaBlIAELDJdJ/6waYBQKjJgqpmGQSLXTmaKZGRv7aGVkkkLAIEbLLzugBCJliwBAWWvzvRyQa+CqmO1umaLdC0KiqWoNhzAo1MvBChKgFHbg0BEIIKqhkybDaczsRxa0GrEDY8+UxtosAM202j0/gRpCLBUpe+v+gKaxaEGpxGJ537QisQtNh3+I2LPr01pBgIXqXR+FFFis3fiic+9AgEBStWGcnktG0R8iFcOmHSGaN3RygKGe5gYuTt0FyCpXrxvRfSetDCBCvPozv71CB3wCnk8x1fAaQwAF8xkbYpNE8NXueMt6bvDUXxAWcz0nkSQg6B/MopPw49CaEU2xrd+DCyHIplB3LawN8OhJZAseJQpsh3UJNrlRGcMKnvkpASCJp3okV+Bc218nDOGNtxsZLgl0ZfVrD6GHJm+8XL8lOjT5HlWnkEjdOXLknNn43eqGCRHjT6LtASKBbvTUu8LZcIfmJ0XoBQgoD1JzM5T0HIgQwvMxrvR1aCDPvTnLYFNE/A5UyRX0JLoLi70bBmkDyKzY2J0zdGKA71A+jGpyHIK6gbQo88EVlhAcew0eHIckFxHy3xz1oULYrvaYn9loLmC9iRdOfZCAUF7EO68X5kyC+Cr2jGHotAChG07cHknLQCpAIoDqAz8TDUFJLhERojr0NAFT+jOXuvjayADEdGd2PvxaGVBWwynW4cvgEyqZJkOGIWneTeUFQx4BoaE0fvAQlaBQmCs+czsYE3QlFVwfuMTJz3UHNI0ApEA5Z4gSnR+GENpDqKxdox0o09jloEgpAFVRHVEERQd8pIJmfkj60hqLJixc6MdCP73rYm8rc6vn1ico/8thUUVQ9Y5AO6eTIy/n7l/hssu0hd2xXX3/68D6eQ5m7OTxeBokCFXjWH0dwSSU4b2KNdj6GTjaSbW+KsK2sRUKgoNv0hkhZTisamPSY3IxveXxtBULAE1O33vZEeLZlZjGZmDUamr3YGVFC8KrDhQ39OpTOvD31oXUAVpZQAoHbD019u32v0nNnjBvz5zt3nH7AsIEFQWs0EgNbUL9qqvlbROFOUW0IQLFAkZIqFU0QE/3cDVlA4IGoDAAAwEgCdASpAAEAAPrVQnkunJKKhqhZtEOAWiWwAuY85As/M8Rvw/ARfCtq+oDbIeYD9pvXd9Bn+A3wDePv3T9JjNVf7dRKTgKBDrjDAlQQ0bxa6gHRh/bn2Of1ub+Z8tXrv8lQOm+wp6uPaujHcoYdPy/+2SiHfzM/6VG1Zoty3eVfRjn+1hWdIpUTFesu7mZmSdcUyafvNccSgAP76An//Rb//omf//oKSfqPhnj8bfTY9xI+/o6Cc09Mz58+x/uf+v3chaavlXVXXEWZ+meNIB3jqD8G8n3TJEUfG/0tjaMUUDt3bPT39ZTXXfOZpPsftH6+rO0QRYHfKOBhT3wl77zWQP+EqI2r5lHcByTRrIk5vKK/HeLhAkk8G6lEoCse9Mhg3QYgDMtpWKAYkKljIfg17g32nF9dSMHZ9uN1oJ0xXquMsrfFUzRuOsE91rVAnkk3Ogl29tPf/1ovA/LnO1qvOlii0Q3er4B0YhdlCszkShZQ+bSxgnGozQ6tEYmJF8m7IeVz1aLftq0iC/iuWzi0U9uRLm+7ZzZ9dP65Dt3Ohsl1pDZL3a3YFriev6m6yFMqGql3l8iKc8ENf+Pz70EREa7HO2g/v8wIofTZikG5hdNB+jPt36fTWNX+0RDmra2lac6yEDspavjGG6PCXX86WkJz/TFdofJl8p06kzRUbvgxr+oIAUkdN2KkA95qLcyCHryHTAf6wDae4RMYnqzRAZ4xUY+mwI14alREG32IT9cXUKU1JiCPvB+Apw5yu4VCrtG3wXcQR9gVQvBIpeiEvp85rGrgqYu6LFNmSCY05Ieu4eTRa5zgI+xAENto6cO+opYz+ecZmAkHmOqgycnp8RxEJkhDrQ3gEBFZPg5F4/URV5tf93ugJijCP0dLKRR0B4CtClGajcIbGQ+xXrI/fSn7o8D/ZcXpC0fZtuRl5IBssjyaVP4FQx+OJFHfMA4Kc8YCn6BXnq0ZXCzJjwdiH+sAEIWoaRBDlK/22Cnv//oRlBOYi1+yfnC4I2jBakh+TqkPuuqgFyf6pqvWoUzPhwB2j8r241j3jM8qy799BAQ8tNJ5TbCs+5GJz6Can72E2QLaI46zw5lWVx5NyA+FOi4d1pMqWAOAPjnfJYN7vn46lrWb8b7Mr3zG/ABQztG+aU7xrWgAA

Ipo Date

2015-11-13T00:00:00.000Z

Market Cap

336385088

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.994

Sentiment Sources

1

Rating

4.625

Target Price

33.7143

Strong Buy

6

Buy

1

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

0

Gross Profit

0

Operating Expenses

19198000

Operating Income

-19198000

Interest Expense

-

Pretax Income

-30614000

Net Income

-30625000

Eps

-2.187429533520027

Dividends Per Share

-

Shares Outstanding

18133968

Income Tax Expense

11000

EBITDA

-30555000

Operating Margin

-

Total Other Income Expense Net

-11416000

Cash

26963000

Short Term Investments

84654000

Receivables

-

Inventories

-

Total Current Assets

113846000

Property Plant Equipment

542000

Total Assets

125100000

Payables

474000

Short Term Debt

438000

Long Term Debt

-

Total Liabilities

33553000

Equity

91547000

Depreciation

59000

Change In Working Capital

-1146000

Cash From Operations

-16365000

Capital Expenditures

0

Cash From Investing

-13261000

Cash From Financing

14369000

Net Change In Cash

-15257000

PE

-

PB

2.8445321922072817

ROE

-33.452761969261694

ROA

-24.480415667466026

FCF

-16365000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

2

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

0

Quarters > 0 > income Statement > gross Profit

0

Quarters > 0 > income Statement > operating Expenses

19198000

Quarters > 0 > income Statement > operating Income

-19198000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-30614000

Quarters > 0 > income Statement > net Income

-30625000

Quarters > 0 > income Statement > eps

-2.187429533520027

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

14000451

Quarters > 0 > income Statement > income Tax Expense

11000

Quarters > 0 > income Statement > EBITDA

-30555000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

-11416000

Quarters > 0 > balance Sheet > cash

26963000

Quarters > 0 > balance Sheet > short Term Investments

84654000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

113846000

Quarters > 0 > balance Sheet > property Plant Equipment

542000

Quarters > 0 > balance Sheet > total Assets

125100000

Quarters > 0 > balance Sheet > payables

474000

Quarters > 0 > balance Sheet > short Term Debt

438000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

33553000

Quarters > 0 > balance Sheet > equity

91547000

Quarters > 0 > cash Flow > net Income

-30625000

Quarters > 0 > cash Flow > depreciation

59000

Quarters > 0 > cash Flow > change In Working Capital

-1146000

Quarters > 0 > cash Flow > cash From Operations

-16365000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-13261000

Quarters > 0 > cash Flow > cash From Financing

14369000

Quarters > 0 > cash Flow > net Change In Cash

-15257000

Quarters > 0 > ratios > PE

-2.187429533520027

Quarters > 0 > ratios > PB

2.8445321922072817

Quarters > 0 > ratios > ROE

-33.452761969261694

Quarters > 0 > ratios > ROA

-24.480415667466026

Quarters > 0 > ratios > FCF

-16365000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

134000

Quarters > 1 > income Statement > gross Profit

-134000

Quarters > 1 > income Statement > operating Expenses

19316000

Quarters > 1 > income Statement > operating Income

-19316000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-20749000

Quarters > 1 > income Statement > net Income

-20765000

Quarters > 1 > income Statement > eps

-1.9174016783382088

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

10829760

Quarters > 1 > income Statement > income Tax Expense

16000

Quarters > 1 > income Statement > EBITDA

-19182000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-1433000

Quarters > 1 > balance Sheet > cash

42290000

Quarters > 1 > balance Sheet > short Term Investments

70972000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

115185000

Quarters > 1 > balance Sheet > property Plant Equipment

686000

Quarters > 1 > balance Sheet > total Assets

126583000

Quarters > 1 > balance Sheet > payables

2366000

Quarters > 1 > balance Sheet > short Term Debt

482000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

22009000

Quarters > 1 > balance Sheet > equity

104574000

Quarters > 1 > cash Flow > net Income

-20765000

Quarters > 1 > cash Flow > depreciation

134000

Quarters > 1 > cash Flow > change In Working Capital

3614000

Quarters > 1 > cash Flow > cash From Operations

-11390000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-70860000

Quarters > 1 > cash Flow > cash From Financing

-469000

Quarters > 1 > cash Flow > net Change In Cash

-82798000

Quarters > 1 > ratios > PE

-1.9174016783382088

Quarters > 1 > ratios > PB

1.9262296173044926

Quarters > 1 > ratios > ROE

-19.85675215636774

Quarters > 1 > ratios > ROA

-16.40425649573797

Quarters > 1 > ratios > FCF

-11390000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

43

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

0

Quarters > 2 > income Statement > gross Profit

0

Quarters > 2 > income Statement > operating Expenses

14669000

Quarters > 2 > income Statement > operating Income

-14669000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-13141000

Quarters > 2 > income Statement > net Income

-13149000

Quarters > 2 > income Statement > eps

-1.2505110604465035

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

10514901

Quarters > 2 > income Statement > income Tax Expense

8000

Quarters > 2 > income Statement > EBITDA

-14534000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1528000

Quarters > 2 > balance Sheet > cash

125046000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

126941000

Quarters > 2 > balance Sheet > property Plant Equipment

949000

Quarters > 2 > balance Sheet > total Assets

138523000

Quarters > 2 > balance Sheet > payables

681000

Quarters > 2 > balance Sheet > short Term Debt

526000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

15908000

Quarters > 2 > balance Sheet > equity

122615000

Quarters > 2 > cash Flow > net Income

-13149000

Quarters > 2 > cash Flow > depreciation

135000

Quarters > 2 > cash Flow > change In Working Capital

1197000

Quarters > 2 > cash Flow > cash From Operations

-9457000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-9457000

Quarters > 2 > ratios > PE

-1.2505110604465035

Quarters > 2 > ratios > PB

1.5950508388043878

Quarters > 2 > ratios > ROE

-10.723810300534192

Quarters > 2 > ratios > ROA

-9.4922864795016

Quarters > 2 > ratios > FCF

-9457000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

43

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

192000

Quarters > 3 > income Statement > cost Of Revenue

87000

Quarters > 3 > income Statement > gross Profit

105000

Quarters > 3 > income Statement > operating Expenses

13416000

Quarters > 3 > income Statement > operating Income

-13311000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-35225000

Quarters > 3 > income Statement > net Income

-35339000

Quarters > 3 > income Statement > eps

-3.3746392977648636

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

10471934

Quarters > 3 > income Statement > income Tax Expense

114000

Quarters > 3 > income Statement > EBITDA

-13243000

Quarters > 3 > income Statement > operating Margin

-6932.8125

Quarters > 3 > income Statement > total Other Income Expense Net

-21914000

Quarters > 3 > balance Sheet > cash

134546000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

611000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

138890000

Quarters > 3 > balance Sheet > property Plant Equipment

1209000

Quarters > 3 > balance Sheet > total Assets

150732000

Quarters > 3 > balance Sheet > payables

283000

Quarters > 3 > balance Sheet > short Term Debt

568000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

17700000

Quarters > 3 > balance Sheet > equity

133032000

Quarters > 3 > cash Flow > net Income

-35339000

Quarters > 3 > cash Flow > depreciation

68000

Quarters > 3 > cash Flow > change In Working Capital

-612000

Quarters > 3 > cash Flow > cash From Operations

-15044000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

67709000

Quarters > 3 > cash Flow > net Change In Cash

52666000

Quarters > 3 > ratios > PE

-3.3746392977648636

Quarters > 3 > ratios > PB

1.4641437578928378

Quarters > 3 > ratios > ROE

-26.564285284743523

Quarters > 3 > ratios > ROA

-23.444922113419846

Quarters > 3 > ratios > FCF

-15044000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-78.35416666666667

Quarters > 3 > health Score

35

Valuation > metrics > PE

-2.187429533520027

Valuation > metrics > PB

2.8445321922072817

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-33.452761969261694

Profitability > metrics > ROA

-26.900374189694855

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.3665111909729429

Risk > metrics > Interest Coverage

-325.3898305084746

Risk > final Score

-1242

Risk > verdict

High

Liquidity > metrics > Current Ratio

124.83114035087719

Liquidity > metrics > Quick Ratio

124.83114035087719

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

11

Prev Risks > 1

18

Prev Risks > 2

58

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:15:26.607Z